ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,590Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 609

$781K Total Retail Price of All Prescriptions

Rank: 48 out of 609

460 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 460 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

9% of this provider’s 460 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 13,005 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 36%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $117 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
FUROSEMIDE 664 657 1 4
SIMVASTATIN 564 544 2 1
AMLODIPINE BESYLATE 457 446 3 2
POTASSIUM CHLORIDE 432 420 4 40
LEVOTHYROXINE SODIUM 399 380 5 7
WARFARIN SODIUM 387 368 6 8
METOPROLOL TARTRATE 350 337 7 9
LISINOPRIL 292 277 8 12
PANTOPRAZOLE SODIUM 288 287 9 29
METOPROLOL SUCCINATE 221 197 10 5
SERTRALINE HCL 209 191 11 61
NAMENDA 207 207 12 36
DONEPEZIL HCL 193 193 13 22
ATORVASTATIN CALCIUM 191 186 14 6
MIRTAZAPINE 191 191 14 58
CARVEDILOL 177 169 16 14
GLIMEPIRIDE 168 165 17 53
CLOPIDOGREL 166 163 18 17
OMEPRAZOLE 159 145 19 3
ATENOLOL 155 153 20 27
NITROGLYCERIN PATCH 152 152 21 120
AZITHROMYCIN 147 142 22 67
PLAVIX 146 143 23 25
LOSARTAN POTASSIUM 132 126 24 24
FENTANYL 129 127 S2 25 66
ZOLPIDEM TARTRATE 123 118 26 18
GABAPENTIN 106 106 27 21
DIOVAN 101 101 28 15
TAMSULOSIN HCL 99 85 29 11
DIGOXIN 99 99 29 33
OXYCODONE-ACETAMINOPHEN 98 79 S2 31 44
RANITIDINE HCL 90 90 32 141
MELOXICAM 89 87 33 55
ALLOPURINOL 89 89 33 75
METOLAZONE 85 85 35 316
ESCITALOPRAM OXALATE 83 83 36 91
BENAZEPRIL HCL 78 78 37 322
FAMOTIDINE 78 74 37 50
DIVALPROEX SODIUM 76 76 39 101
CARBIDOPA-LEVODOPA 72 56 40 49
METFORMIN HCL 70 69 41 10
NEXIUM 70 70 41 13
AMIODARONE HCL 67 65 43 158
TRAMADOL HCL 67 67 43 39
ISOSORBIDE MONONITRATE ER 67 67 43 62
HYDRALAZINE HCL 67 61 43 133
ADVAIR DISKUS 66 66 47 28
LEVOFLOXACIN 64 58 48 127
ACETAMINOPHEN-CODEINE 64 59 S3 48 136
LANTUS 63 63 50 82
LIDODERM 63 44 50 81
TRIAMTERENE-HCTZ 62 61 52 204
RISPERIDONE 61 56 53 107
CRESTOR 61 54 53 16
LEVETIRACETAM 60 56 55 70
DILTIAZEM HCL 59 59 56 377
ALENDRONATE SODIUM 59 59 56 54
HYDROCODONE-ACETAMINOPHEN 59 55 S3 56 30
KLOR-CON 10 57 53 59 288
AMLODIPINE BESYLATE-BENAZEPRIL 55 55 60 88
TRAZODONE HCL 54 47 61 113
QUETIAPINE FUMARATE 54 54 61 116
PAROXETINE HCL 51 49 63 123
PREDNISONE 51 51 63 26
CLONIDINE HCL 50 50 65 83
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 17, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.